1. Ahuja V, Coleman RE, Herndon J, Patz Jr EF (1998) The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma. Cancer 83: 918–924
2. Braams JW, Pruim J, Freling NJM, Nikkels PG, Roodenburg JL, Boering G, Vaalburg W, Vermey A (1995) Detection of lymph node metastases of squamous cell cancer of the head and neck with FDG-PET and MRI. J Nucl Med 36: 211–216
3. Conti PS, Strauss LG (1991) The applications of PET in clinical oncology. J Nucl Med 32: 623–648
4. Haberkorn U, Strauss L, Reisser CH, Haag D, Dimitrikopoulou A, Ziegler S, Oberdorfer F, Rudat V, van Kaick G (1991) Glucose uptake, perfusion and cell proliferation in head and neck tumours: relation of positron emission tomography to flow cytometry. J Nucl Med 32: 1548–1555
5. Hain SF, O'Doherty MJ, Timothy AR, Leslie MD, Harper PG, Huddart RA (2000) Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse. Br J Cancer 83: 863–869